Skip to main content
SpringerLink
Log in

Cancer du canal anal

  • Chapter
Les cancers digestifs

Part of the book series: Oncologie Pratique ((ONCOLPRAT))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Jemal A, Tiwari RC, Murray T et al. (2004) Cancer statistics 2004. CA Cancer J Clin 54: 8–29

    PubMed  Google Scholar 

  2. Johnson LG, Madeleine MM, Newcomer LM et al. (2004) Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000. Cancer 101: 281–8

    Article  PubMed  Google Scholar 

  3. Holly EA, Whittemore AS, Aston DA et al. (1989) Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst 81: 1726–31

    CAS  PubMed  Google Scholar 

  4. Frisch M, Olsen JH, Bautz A, Melbye M (1994) Benign anal lesions and the risk of anal cancer. N Engl J Med 331: 300–2

    Article  CAS  PubMed  Google Scholar 

  5. Slater G, Greenstein A, Aufses AH Jr (1984) Anal carcinoma in patients with Crohn’s disease. Ann Surg 199: 348–50

    CAS  PubMed  Google Scholar 

  6. Frisch M, Johansen C (2000) Anal carcinoma in inflammatory bowel disease. Br J Cancer 83: 89–90

    CAS  PubMed  Google Scholar 

  7. Daling JR, Weiss NS, Hislop TG et al. (1987) Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 317: 973–7

    CAS  PubMed  Google Scholar 

  8. Frisch M, Glimelius B, van den Brule AJ et al. (1997) Sexually transmitted infection as a cause of anal cancer. N Engl J Med 337: 1350–8

    Article  CAS  PubMed  Google Scholar 

  9. Melbye M, Sprogel P (1991) Aetiological parallel between anal cancer and cervical cancer. Lancet 338: 657–9

    Article  CAS  PubMed  Google Scholar 

  10. Frisch M, Olsen JH, Melbye M (1994) Malignancies that occur before and after anal cancer: clues to their etiology. Am J Epidemiol 140: 12–9

    CAS  PubMed  Google Scholar 

  11. Palefsky JM, Holly EA, Hogeboom CJ et al. (1998) Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in VIH-positive and VIH-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 17: 314–9

    CAS  PubMed  Google Scholar 

  12. Palefsky JM, Holly EA, Gonzalez J et al. (1991) Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res 51: 1014–9

    CAS  PubMed  Google Scholar 

  13. Palefsky JM, Gonzales J, Greenblatt RM et al. (1990) Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV VIH disease. JAMA 263: 2911–6

    Article  CAS  PubMed  Google Scholar 

  14. Palefsky JM, Holly EA, Ralston ML et al. (1998) High incidence of anal high-grade squamous intra-epithelial lesions among VIH-positive and VIH-negative homosexual and bisexual men. AIDS 12: 495–503

    Article  CAS  PubMed  Google Scholar 

  15. Biggar RJ, Burnett W, Mikl J, Nasca P (1989) Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer 43: 979–85

    CAS  PubMed  Google Scholar 

  16. Arends MJ, Benton EC, McLaren KM et al. (1997) Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer 75: 722–8

    CAS  PubMed  Google Scholar 

  17. Sood AK (1991) Cigarette smoking and cervical cancer: Meta-analysis and critical review of recent studies. Am J Prev Med 7: 208–13

    CAS  PubMed  Google Scholar 

  18. Klas JV, Rothenberger DA, Wong WD, Madoff RD (1999) Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 85: 1686–93

    Article  CAS  PubMed  Google Scholar 

  19. Touboul E, Schlienger M, Buffat L et al. (1994) Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer 73: 1569–79

    CAS  PubMed  Google Scholar 

  20. Frost DB, Richards PC, Montague ED et al. (1984) Epidermoid cancer of the anorectum. Cancer 53: 1285–93

    CAS  PubMed  Google Scholar 

  21. Bartelink H, Roelofsen F, Eschwege F et al. (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15: 2040–9

    CAS  PubMed  Google Scholar 

  22. Nigro ND, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17: 354–9

    CAS  PubMed  Google Scholar 

  23. (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 348: 1049–54

    Google Scholar 

  24. Flam M, John M, Pajak TF et al. (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14: 2527–39

    CAS  PubMed  Google Scholar 

  25. Doci R, Zucali R, La Monica G et al. (1996) Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. J Clin Oncol 14: 3121–5

    CAS  PubMed  Google Scholar 

  26. Peiffert D, Seitz JF, Rougier P et al. (1997) Preliminary results of a phase II study of highdose radiation therapy and neoadjuvant plus concomitant 5-fluoro-uracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study. Ann Oncol 8: 575–81

    Article  CAS  PubMed  Google Scholar 

  27. Allal AS, Mermillod B, Roth AD et al. (1997) Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys 39: 1099–105

    Article  CAS  PubMed  Google Scholar 

  28. John M, Pajak T, Flam M et al. (1996) Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am 2: 205

    PubMed  Google Scholar 

  29. Allal AS, Laurencet FM, Reymond MA et al. (1999) Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer 86: 405–9

    Article  CAS  PubMed  Google Scholar 

  30. Hoffman R, Welton ML, Klencke B et al. (1999) The significance of pretreatment CD4 count on the outcome and treatment tolerance of VIH-positive patients with anal cancer. Int J Radiat Oncol Biol Phys 44: 127–31

    Article  CAS  PubMed  Google Scholar 

  31. Faivre C, Rougier P, Ducreux M et al. (1999) Association 5-fluorouracile et cisplatine dans le traitement du cancer du canal anal métastatique. Bull Cancer 86: 861–5

    CAS  PubMed  Google Scholar 

  32. Ajani JA, Carrasco CH, Jackson DE, Wallace S (1989) Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med 87: 221–4

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. G. Declety
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France

About this chapter

Cite this chapter

Declety, G. (2006). Cancer du canal anal. In: Les cancers digestifs. Oncologie Pratique. Springer, Paris. https://doi.org/10.1007/2-287-30874-1_8

Download citation

  • DOI: https://doi.org/10.1007/2-287-30874-1_8

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-22087-6

  • Online ISBN: 978-2-287-30874-1

Publish with us

Policies and ethics

Search

Navigation